Markets & Regulations

© Getty Images

Bio International 2024

Cytiva: 'BIO is a very important convention for us'

By Isabel Cameron

Life sciences business Cytiva is set to launch its new platform, designed to accelerate the manufacturing process for autologous CAR-T cell therapies. Find out more about the company's priorities, market challenges, expansion plans and more.

© Getty Images

Bio International 2024

Ecolab Life Sciences to unveil bioquell qube and more at BIO 2024

By Isabel Cameron

Ahead of Bio 2024, we caught up with Matt Cokely, global technical consultant strategic leader, and Helen Gates, marketing director, at Ecolab Life Sciences to find out what the company is planning for the event and how it is navigating current challenges...

© Getty Images

Bio International 2024

Novartis to showcase next-gen manufacturing solutions at BIO 2024

By Isabel Cameron

Before the industry is set to arrive in San Diego for Bio International 2024, we spoke with Dr. Harald Oberegger, global head business development at Novartis Contract Manufacturing. At the event, the company will be showcasing its cutting-edge technologies,...

© Enhanc3D Genomics

How Hazel Jones is charting new horizons in genomics

By Isabel Cameron

Hazel Jones is the CEO at Enhanc3D Genomics. We sat down with her to discuss her leap of faith into 3D genomics, and how she is scaling the business and driving operational change.

© Getty Images

CPHI North America 2024

Torbay Pharma: 'We are all about making sterile supply simple'

By Isabel Cameron

Torbay Pharmaceuticals is a sterile injectable contract manufacturer and licence holder based in Devon, UK. We spoke with CEO Emma Rooth about the company's heritage and how it is striving to support the U.S. market.

© Getty Images

CPHI North America 2024

Selkirk Pharma: Adapting to regulatory shifts and market demand

By Isabel Cameron

Ahead of CPHI North America, we caught up with Lisa Stiles, director, business development at Selkirk Pharma, an exhibitor at the event, to find out how the CMO is navigating regulatory changes, challenges and more.